Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 36, 2022 - Issue 1
159
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

Two new triterpenoid-chromone hybrids from the rhizomes of Actaea cimicifuga L. (syn. Cimicifuga foetida L.) and their cytotoxic activities

, , , &
Pages 193-199 | Received 14 Aug 2019, Accepted 17 May 2020, Published online: 05 Jun 2020

References

  • Agretti P, De Marco G, Dimida A, Ferrarini E, Tonacchera M. 2018. In vitro effects of natural phytoestrogens on sodium/iodide symporter mediated thyroid iodide uptake by using a differentiated TSH-dependent cell line. J Funct Foods. 40:438–446.
  • Ahn BS, Yang M, Jang H, Lee HJ, Moon C, Kim JC, Jung U, Jo SK, Jang JS, Kim SH. 2012. Evaluation of the anti-osteoporotic potential of Cimicifuga heracleifolia in female mice. Phytother Res. 26(5):663–668.
  • Ahn KH, Yi KW, Park HT, Shin JH, Hur JY, Kim SH, Kim T. 2013. Anti-proliferative effect of Klimaktoplan® on human breast cancer cells. Arch Gynecol Obstet. 288(4):833–838.
  • Archer I. 1997. Epoxide hydrolases as asymmetric catalysts. Tetrahedron. 53(46):15617–15662.
  • Byron JR. 2007. Alternative treatments of vasomotor symptoms of menopause. Ann Intern Med. 147(5):346–347.
  • Chen JY, Li PL, Tang XL, Wang SJ, Jiang YT, Shen L, Xu BM, Shao YL, Li GQ. 2014. Cycloartane triterpenoids and their glycosides from the rhizomes of Cimicifuga foetida. J Nat Prod. 77(9):1997–2005.
  • Editorial Committee of Flora of China CAS. 1979. Flora of China (Zhongguo Zhiwu Zhi). Beijing: Science Press; vol. 27, p. 93–100.
  • Fang ZJ, Zhang T, Chen SX, Wang YL, Zhou CX, Mo JX, Wu YJ, Xu YK, Lin LG, Gan LS. 2019. Cycloartane triterpenoids from Actaea vaginata with anti-inflammatory effects in LPS-stimulated RAW264.7 macrophages. Phytochemistry. 160:1–10.
  • He K, Pauli GF, Zheng B, Wang H, Bai N, Peng T, Roller M, Zheng Q. 2006. Cimicifuga species identification by high performance liquid chromatography-photodiode array/mass spectrometric/evaporative light scattering detection for quality control of black cohosh products. J Chromatogr A. 1112(1–2):241–254.
  • Kolios L, Schumann J, Sehmisch S, Rack T, Tezval M, Seidlova-Wuttke D, Frosch KH, Stuermer KM, Stuermer EK. 2010. Effects of black cohosh (Cimicifuga racemosa) and estrogen on metaphyseal fracture healing in the early stage of osteoporosis in ovariectomized rats. Planta Med. 76(9):850–857.
  • Li JX, Liu J, He CC, Yu ZY, Du Y, Kadota S, Seto H. 2007. Triterpenoids from Cimicifugae rhizoma, a novel class of inhibitors on bone resorption and ovariectomy-induced bone loss. Maturitas. 58(1):59–69.
  • Li JX, Yu ZY. 2006. Cimicifugae rhizoma: from origins, bioactive constituents to clinical outcomes. Curr Med Chem. 13(24):2927–2951.
  • Mahady GB, Fabricant D, Chadwick LR, Dietz B. 2002. Black cohosh: an alternative therapy for menopause? Nutr Clin Care. 5(6):283–289.
  • Mahady G, Low DT, Sarma ND, Giancaspro GI, Griffiths J. 2010. The causal relationship between the use of black cohosh-containing products and hepatotoxicity. Menopause. 17(5):1088–1089.
  • Monks A, Scudiero D, Skehan P, Shoemaker R, Paull K, Vistica D, Hose C, Langley J, Cronise P, Vaigro-Wolff A, et al. 1991. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J Natl Cancer Inst. 83(11):757–766.
  • Nian Y, Yang J, Liu TY, Luo Y, Zhang JH, Qiu MH. 2015. New anti-angiogenic leading structure discovered in the fruit of Cimicifuga yunnanensis. Sci Rep. 5:9026.
  • Nian Y, Zhang YL, Chen JC, Lu L, Qiu MH, Qing C. 2010. Cytotoxic Chemical constituents from the roots of Cimicifuga foetida [corrected]. J Nat Prod. 73(2):93–98.
  • Qiu SX, Dan C, Ding LS, Peng S, Chen SN, Farnsworth NR, Nolta J, Gross ML, Zhou P. 2007. A triterpene glycoside from black cohosh that inhibits osteoclastogenesis by modulating RANKL and TNFalpha signaling pathways. Chem Biol. 14(7):860–869.
  • Qiu F, Imai A, McAlpine JB, Lankin DC, Burton I, Karakach T, Farnsworth NR, Chen SN, Pauli GF. 2012. Dereplication, residual complexity, and rational naming: the case of the Actaea triterpenes. J Nat Prod. 75(3):432–443.
  • Reed LJ, Muench H. 1938. A simple method of estimating fifty per cent endpoints12. Am J Epidemiol. 27(3):493–497.
  • Sasaki H, Taguchi H, Endo T, Yosioka I. 1982. The constituents of Ledebouriella seseloides Wolff. I. Structures of three new chromones. Chem Pharm Bull. 30(10):3555–3562.
  • Shi QQ, Lu J, Peng XR, Li DS, Zhou L, Qiu MH. 2018. Cimitriteromone A-G, macromolecular triterpenoid-chromone hybrids from the rhizomes of Cimicifuga foetida. J Org Chem. 83(17):10359–10369.
  • Sun H, Huang M, Yao N, Hu J, Li Y, Chen L, Hu N, Ye W, Chi-Shing Tai W, Zhang D, et al. 2017. The cycloartane triterpenoid ADCX impairs autophagic degradation through Akt overactivation and promotes apoptotic cell death in multidrug-resistant HepG2/ADM cells. Biochem Pharmacol. 146:87–100.
  • Thao NP, Kim JH, Thuy Luyen BT, Dat NT, Kim YH. 2017. In silico investigation of cycloartane triterpene derivatives from Cimicifuga dahurica (Turcz.) Maxim. roots for the development of potent soluble epoxide hydrolase inhibitors. Int J Biol Macromol. 98:526–534.
  • Thao NP, Luyen B-T, Lee JS, Kim JH, Dat NT, Kim YH. 2017. Inhibition potential of cycloartane-type glycosides from the roots of Cimicifuga dahurica against soluble epoxide hydrolase. J Nat Prod. 80(6):1867–1875.
  • Wuttke W, Seidlova-Wuttke D, Gorkow C. 2003. The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers. Maturitas Suppl. 44:S67–S77.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.